James Quigley Analyst PerformanceExecutive Director, European Pharma & Biotech Equity Research at The Goldman Sachs GroupJames Quigley is a stock analyst at The Goldman Sachs Group in the healthcare sector, covering 8 publicly traded companies. Over the past year, James Quigley has issued 6 stock ratings, including buy and hold recommendations. While full access to James Quigley's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights James Quigley's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings14 Last 6 YearsBuy Recommendations64.29% 9 Buy RatingsCompanies Covered8 Unique Companies Ratings Distribution14RatingsDistribution of strong buy, buy, hold, and sell ratings by James Quigley.RatingPercentageCount Strong Buy21.4%3 ratings Buy42.9%6 ratings Hold28.6%4 ratings Sell7.1%1 ratingsOut of 14 total stock ratings issued by James Quigley at The Goldman Sachs Group, the majority (42.9%) have been Buy recommendations, followed by 28.6% Hold, 21.4% Strong Buy, and 7.1% Sell.Best & Worst CallsBest Call000.0%KYMRJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MKGAFSep 2024Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ37.5% of companies on NASDAQ3 companiesOTCMKTS37.5% of companies on OTCMKTS3 companiesNYSE25.0% of companies on NYSE2 companiesJames Quigley, an analyst at The Goldman Sachs Group, currently covers 8 companies listed on NASDAQ, OTCMKTS and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare8 companies100.0%James Quigley of The Goldman Sachs Group specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentagePHARMACEUTICALS5 companies62.5%BIOTECHNOLOGY2 companies25.0%HEALTHCARE EQUIPMENT & SUPPLIES1 company12.5% James Quigley's Ratings History at The Goldman Sachs Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsKYMRKymera Therapeutics10/27/2026Boost Price Target$114.84$146.00Overweight$0.0000.00% ROINVONovo Nordisk A/S3/2/2026Downgrade$37.50$41.00Neutral$0.0000.00% ROIKYMRKymera Therapeutics2/26/2026Reiterated Rating$95.03$123.00Overweight$0.0000.00% ROINVONovo Nordisk A/S1/22/2026Reiterated Rating$62.30Buy$0.0000.00% ROIKYMRKymera Therapeutics12/9/2025Boost Price Target$94.30$127.00Overweight$0.0000.00% ROINVONovo Nordisk A/S11/28/2025Lower Price Target$48.75$54.00Buy$0.0000.00% ROINVSNovartis9/12/2025Reiterated Rating$127.62$118.00Sell$000.0000.00% ROIBAYRYBayer Aktiengesellschaft6/5/2025Upgrade$7.59Strong-Buy$00.0000.00% ROIKYMRKymera Therapeutics6/3/2025Upgrade$43.13$79.00Overweight$00.0000.00% ROISNYSanofi3/21/2025Initiated Coverage$57.79$65.00Neutral$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
